IKK/IκB inhibitor Bay 65-1942 R form, Purity ≥98%

Cat. No.: X23-10-ZQ776

IKK/IκB inhibitor Bay 65-1942 R form, Purity ≥98%

Synonym: 758683-21-5; Bay 65-1942 (R form); Bay 65-1942 R form; Bay 65-1942(R form); (7Z)-7-[2-(Cyclopropylmethoxy)-6-oxocyclohexa-2,4-dien-1-ylidene]-5-[(3R)-piperidin-3-yl]-1,4,7,8-tetrahydro-2H-pyrido[2,3-d][1,3]oxazin-2-one; IKK/IκB inhibitor

  • CAS Number: 758683-21-5
  • Compound CID: 136091530
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Bay 65-1942 R form modulates IKK-IκB signaling pathway, which plays a key role in inflammation and immune responses.
Molecular Weight
395.45
Molecular Formula
C22H25N3O4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Bay 65-1942 R form can be used to investigate its specific inhibition of IκB kinase in the NF-κB pathway.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.